Eyebot, the US company developing a platform combining self-service vision test kiosks with remote eye doctor prescriptions, has announced that it has raised $20 million in Series A funding, with global private equity fund General Catalyst as the round leader. AlleyCorp, Bauskunst, Village Global and Ubiquity Investors, all returning investors, ...

Buying a membership today will give you:
To continue reading this article register now.